Loading…

Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study

Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Fas...

Full description

Saved in:
Bibliographic Details
Published in:Health science reports 2023-01, Vol.6 (1), p.e1041-n/a
Main Authors: Lingani, Moussa, Cissé, Assana, Tialla, Dieudonné, Ilboudo, Abdoul Kader, Savadogo, Madi, Sawadogo, Catherine, Gampini, Sandrine, Tarnagda, Grissoum, Tao, Maria, Diagbouga, Serge, Bamba, Sanata, Tarnagda, Zekiba
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103
cites cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103
container_end_page n/a
container_issue 1
container_start_page e1041
container_title Health science reports
container_volume 6
creator Lingani, Moussa
Cissé, Assana
Tialla, Dieudonné
Ilboudo, Abdoul Kader
Savadogo, Madi
Sawadogo, Catherine
Gampini, Sandrine
Tarnagda, Grissoum
Tao, Maria
Diagbouga, Serge
Bamba, Sanata
Tarnagda, Zekiba
description Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso. Methods COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols. Results Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected. Conclusions The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.
doi_str_mv 10.1002/hsr2.1041
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb</doaj_id><sourcerecordid>2762819449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</originalsourceid><addsrcrecordid>eNp1ksFuEzEQhi0EolXogRdAlrjAIdT2er02B6QQUVqpElILXC3v7jhx2NjB3k0VTjwCz8iT4G1C1SJxsUcz3_wa_foRek7JG0oIO12myHLF6SN0zAolp1IW5eN79RE6SWlFMksYL6V6io4KIRgpKTlGv-bBeQtN74JP-Mb1S3w9u7r-_TMPvuaX4a2Jzvg-YeNbnNluAP_D4K2LQ8LtEJ1f4H4JmBGq8DzE4M1h5hKYBHiTF2HtmryM3w_xm_MGn5kU3uIZTkPcgus64xvAqR_a3TP0xJouwcnhn6AvZx8-z8-nl58-Xsxnl9OmJIpOja0tBQqCGAlEQltaU4iCgyqZEmWh6saSjEgiLeGEC95yW7YVsXWR90gxQRd73TaYld5EtzZxp4Nx-rYR4kKb2LumA51Ns7KGRra14NlCUwsghYWqElC1WXCC3u21NkO9hrYB30fTPRB9OPFuqRdhq5WktODjMa8OAjF8HyD1eu1SA6MvEIakWSWYpIpzldGX_6CrMESfrRopqcpKiJF6vaeaGFKKYO-OoUSPsdFjbPQYm8y-uH_9Hfk3JBk43QM3roPd_5X0-fUVu5X8A1BGz4s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2768957669</pqid></control><display><type>article</type><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</creator><creatorcontrib>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</creatorcontrib><description>Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso. Methods COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols. Results Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected. Conclusions The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</description><identifier>ISSN: 2398-8835</identifier><identifier>EISSN: 2398-8835</identifier><identifier>DOI: 10.1002/hsr2.1041</identifier><identifier>PMID: 36620510</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Airports ; Burkina Faso ; Coronaviruses ; COVID-19 vaccines ; COVID‐19 ; Disease prevention ; Health surveillance ; Infections ; Influenza ; Mutation ; Original Research ; Pandemics ; SARS‐CoV‐2 ; Severe acute respiratory syndrome coronavirus 2 ; Software ; Statistical analysis ; Thermal cycling ; variant ; Viral infections ; Viruses</subject><ispartof>Health science reports, 2023-01, Vol.6 (1), p.e1041-n/a</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</citedby><cites>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</cites><orcidid>0000-0002-5651-2035</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2768957669?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2768957669?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11543,25733,27903,27904,36991,36992,38495,43874,44569,46030,46454,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36620510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lingani, Moussa</creatorcontrib><creatorcontrib>Cissé, Assana</creatorcontrib><creatorcontrib>Tialla, Dieudonné</creatorcontrib><creatorcontrib>Ilboudo, Abdoul Kader</creatorcontrib><creatorcontrib>Savadogo, Madi</creatorcontrib><creatorcontrib>Sawadogo, Catherine</creatorcontrib><creatorcontrib>Gampini, Sandrine</creatorcontrib><creatorcontrib>Tarnagda, Grissoum</creatorcontrib><creatorcontrib>Tao, Maria</creatorcontrib><creatorcontrib>Diagbouga, Serge</creatorcontrib><creatorcontrib>Bamba, Sanata</creatorcontrib><creatorcontrib>Tarnagda, Zekiba</creatorcontrib><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><title>Health science reports</title><addtitle>Health Sci Rep</addtitle><description>Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso. Methods COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols. Results Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected. Conclusions The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</description><subject>Airports</subject><subject>Burkina Faso</subject><subject>Coronaviruses</subject><subject>COVID-19 vaccines</subject><subject>COVID‐19</subject><subject>Disease prevention</subject><subject>Health surveillance</subject><subject>Infections</subject><subject>Influenza</subject><subject>Mutation</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>SARS‐CoV‐2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Thermal cycling</subject><subject>variant</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>2398-8835</issn><issn>2398-8835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ksFuEzEQhi0EolXogRdAlrjAIdT2er02B6QQUVqpElILXC3v7jhx2NjB3k0VTjwCz8iT4G1C1SJxsUcz3_wa_foRek7JG0oIO12myHLF6SN0zAolp1IW5eN79RE6SWlFMksYL6V6io4KIRgpKTlGv-bBeQtN74JP-Mb1S3w9u7r-_TMPvuaX4a2Jzvg-YeNbnNluAP_D4K2LQ8LtEJ1f4H4JmBGq8DzE4M1h5hKYBHiTF2HtmryM3w_xm_MGn5kU3uIZTkPcgus64xvAqR_a3TP0xJouwcnhn6AvZx8-z8-nl58-Xsxnl9OmJIpOja0tBQqCGAlEQltaU4iCgyqZEmWh6saSjEgiLeGEC95yW7YVsXWR90gxQRd73TaYld5EtzZxp4Nx-rYR4kKb2LumA51Ns7KGRra14NlCUwsghYWqElC1WXCC3u21NkO9hrYB30fTPRB9OPFuqRdhq5WktODjMa8OAjF8HyD1eu1SA6MvEIakWSWYpIpzldGX_6CrMESfrRopqcpKiJF6vaeaGFKKYO-OoUSPsdFjbPQYm8y-uH_9Hfk3JBk43QM3roPd_5X0-fUVu5X8A1BGz4s</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Lingani, Moussa</creator><creator>Cissé, Assana</creator><creator>Tialla, Dieudonné</creator><creator>Ilboudo, Abdoul Kader</creator><creator>Savadogo, Madi</creator><creator>Sawadogo, Catherine</creator><creator>Gampini, Sandrine</creator><creator>Tarnagda, Grissoum</creator><creator>Tao, Maria</creator><creator>Diagbouga, Serge</creator><creator>Bamba, Sanata</creator><creator>Tarnagda, Zekiba</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5651-2035</orcidid></search><sort><creationdate>202301</creationdate><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><author>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Airports</topic><topic>Burkina Faso</topic><topic>Coronaviruses</topic><topic>COVID-19 vaccines</topic><topic>COVID‐19</topic><topic>Disease prevention</topic><topic>Health surveillance</topic><topic>Infections</topic><topic>Influenza</topic><topic>Mutation</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>SARS‐CoV‐2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Thermal cycling</topic><topic>variant</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lingani, Moussa</creatorcontrib><creatorcontrib>Cissé, Assana</creatorcontrib><creatorcontrib>Tialla, Dieudonné</creatorcontrib><creatorcontrib>Ilboudo, Abdoul Kader</creatorcontrib><creatorcontrib>Savadogo, Madi</creatorcontrib><creatorcontrib>Sawadogo, Catherine</creatorcontrib><creatorcontrib>Gampini, Sandrine</creatorcontrib><creatorcontrib>Tarnagda, Grissoum</creatorcontrib><creatorcontrib>Tao, Maria</creatorcontrib><creatorcontrib>Diagbouga, Serge</creatorcontrib><creatorcontrib>Bamba, Sanata</creatorcontrib><creatorcontrib>Tarnagda, Zekiba</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Health science reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lingani, Moussa</au><au>Cissé, Assana</au><au>Tialla, Dieudonné</au><au>Ilboudo, Abdoul Kader</au><au>Savadogo, Madi</au><au>Sawadogo, Catherine</au><au>Gampini, Sandrine</au><au>Tarnagda, Grissoum</au><au>Tao, Maria</au><au>Diagbouga, Serge</au><au>Bamba, Sanata</au><au>Tarnagda, Zekiba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</atitle><jtitle>Health science reports</jtitle><addtitle>Health Sci Rep</addtitle><date>2023-01</date><risdate>2023</risdate><volume>6</volume><issue>1</issue><spage>e1041</spage><epage>n/a</epage><pages>e1041-n/a</pages><issn>2398-8835</issn><eissn>2398-8835</eissn><abstract>Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso. Methods COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols. Results Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected. Conclusions The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36620510</pmid><doi>10.1002/hsr2.1041</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5651-2035</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2398-8835
ispartof Health science reports, 2023-01, Vol.6 (1), p.e1041-n/a
issn 2398-8835
2398-8835
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb
source Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Airports
Burkina Faso
Coronaviruses
COVID-19 vaccines
COVID‐19
Disease prevention
Health surveillance
Infections
Influenza
Mutation
Original Research
Pandemics
SARS‐CoV‐2
Severe acute respiratory syndrome coronavirus 2
Software
Statistical analysis
Thermal cycling
variant
Viral infections
Viruses
title Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A36%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coinfections%20with%20SARS%E2%80%90CoV%E2%80%902%20variants%20and%20influenza%20virus%20during%20the%202019%20Coronavirus%20disease%20pandemic%20in%20Burkina%20Faso:%20A%20surveillance%20study&rft.jtitle=Health%20science%20reports&rft.au=Lingani,%20Moussa&rft.date=2023-01&rft.volume=6&rft.issue=1&rft.spage=e1041&rft.epage=n/a&rft.pages=e1041-n/a&rft.issn=2398-8835&rft.eissn=2398-8835&rft_id=info:doi/10.1002/hsr2.1041&rft_dat=%3Cproquest_doaj_%3E2762819449%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2768957669&rft_id=info:pmid/36620510&rfr_iscdi=true